"remember ph2 trials have a historical average of 20% success"
Are you sure - that sounds far too low?
In the area of tbi - The success rate was 0% for a long time. Hence lots of pharma companies gave up looking. So areas like this bring the success rate down.
What I like about ftt's drug is that it helps the patient to heal themselves.